NYSE
CLX
Last Price
US $96.42
KEY FIGURES
MKT CAP
$11.8B
EPS
TTM
$6.23
PEG
TTM
1.55x
P/E
TTM
15.78x
P/S
TTM
1.66x
YIELD
5.09%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
2826.17%
Return on equity
ROIC: 16.67%
Valuation History
15.8X
Price to Earnings
EV/EBITDA: 11.5X
Cash flow
Profit margin
1.11%
(FY vs FY)
EBITDA Y/Y
-1.10%
(FY vs FY)
Cash flow Y/Y
-10.05%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $96.42
-74.48%
Default assumptions
EBITDA Multiple
Fair Value
Market $96.42
-39.86%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
The Clorox Company cash flow to debt ratio of 34.06% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial stability - Healthy cash flow growth.
The Clorox Company's free cash flow has increased 57.56% from $483.00M last year to $761.00M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
The Clorox Company's debt to equity ratio is -66.96, signaling that the company spent its equity and risk bankruptcy.
Financial risk - Healthy debt to equity ratio development.
The Clorox Company's debt to equity ratio is -66.96, signaling that the company spent its equity and risk bankruptcy.
Financial stability - Net debt/EBITDA.
The Clorox Company has a net debt to EBITDA ratio of 1.96x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
The Clorox Company's interest coverage ratio of 10.93 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
The Clorox Company's profit margin has increased (183.30%) in the last year from 3.95% to 11.18%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
The Clorox Company's short-term liabilities of $1.92G exceed its short-term assets of $1.61G, signaling financial risk
Increasing performance - ROA.
The Clorox Company's return on assets of 11.75% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
The Clorox Company's return on equity of 2.83K%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
The Clorox Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
The Clorox Company had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
The Clorox Company has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
The Clorox Company has a free cash flow yield of 6.45%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
The Clorox Company's yearly earnings has increased 189.29% since last year from $280.00M to $810.00M, signaling increasing performance
Increasing performance - Healthy revenue growth.
The Clorox Company's yearly revenue has increased 0.16% since last year from $7.09G to $7.10G, signaling increasing performance
Increasing performance - ROIC.
ROIC 16.67% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
The Clorox Company's 3-year revenue CAGR of -0.01% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
The Clorox Company had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
The Clorox Company had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
The Clorox Company is overvalued relative to its fair value price of 24.61 based on Discounted Cash Flow model
Undervalued - Earnings yield.
The Clorox Company has an earnings yield of 6.39%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
The Clorox Company is overvalued relative to its fair value price of 57.99 based on EBITDA multiple model
Undervalued - EV/EBITDA.
The Clorox Company has an EV/EBITDA ratio of 11.51x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
The Clorox Company has a PEG-ratio over 1 which is considered overvalued
Overvalued - P/B ratio.
The Clorox Company has negative shareholder equity; price-to-book is not meaningful and the check fails
Undervalued - P/S ratio.
The Clorox Company has a price-to-sales ratio of 1.74x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue